Another biotech startup announced plans to move into downtown Chicago this week in just the latest addition to the city’s burgeoning life-sciences sector — an industry that may help reshape Chicago’s real estate coming out of Covid.
Arriving in the Windy City is Interactome Bio, a Kalamazoo, Michigan-based biotechnology research startup that will expand to Portal Innovations’ lab space in the West Loop.
“I don’t think I’ve seen the level of activity and energy that we’ve seen here over the past two years,” said John Conrad, president and CEO of the Illinois Biotechnology Innovation Organization, to the Chicago Business Journal. “And it’s really been driven by new groups like Portal Innovations coming in and not only providing companies with startup space but also helping them attract venture funding.”
Read the rest of this article on the Chicago Business Journal’s Website